Outcome measures in CIDP: A scoping and mapping review

Authors: Rajabally YA, Boggia GM, Riley D, Riley S, Peatman J, Noel W, Gary C, Nobile-Orazio E.

Editor's Choice
Journal of the Neurological Sciences REVIEW ARTICLE | Volume 476, 123654. August 12, 2025

DOI: https://doi.org/10.1016/j.jns.2025.123654

CIDP is a rare autoimmune disorder with varying symptom presentations. This heterogenous nature challenges standardizing disease monitoring and assessing treatment response. This study aimed to provide a comprehensive overview of clinical outcome assessments (COAs) used in CIDP.

This article mentions how it identifies the INCAT, I-RODS, and MRC score as core measures that evaluate important, although not exhaustive, aspects of CIDP disease experience.